Department of Genetics and Stanley S. Scott Cancer Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA.
Department of Oncology, the First Affiliated Hospital of Shandong First Medical University, Jinan, 250014, China.
Acta Pharmacol Sin. 2021 Jul;42(7):1018-1026. doi: 10.1038/s41401-020-00540-0. Epub 2020 Oct 9.
MicroRNAs (miRNAs) are recognized as an essential component of the RNA family, exerting multiple and intricate biological functions, particularly in the process of tumorigenesis, proliferation, and metastatic progression. MiRNAs are altered in gastric cancer (GC), showing activity as both tumor suppressors and oncogenes, although their true roles have not been fully understood. This review will focus upon the recent advances of miRNA studies related to the regulatory mechanisms of gastric tumor cell proliferation, apoptosis, and cell cycle. We hope to provide an in-depth insight into the mechanistic role of miRNAs in GC development and progression. In particular, we summarize the latest studies relevant to miRNAs' impact upon the epithelial-mesenchymal transition, tumor microenvironment, and chemoresistance in GC cells. We expect to elucidate the molecular mechanisms involving miRNAs for better understanding the etiology of GC, and facilitating the development of new treatment regimens for the treatment of GC.
微小 RNA(miRNA)被认为是 RNA 家族的重要组成部分,具有多种复杂的生物学功能,特别是在肿瘤发生、增殖和转移进展的过程中。miRNA 在胃癌(GC)中发生改变,表现出作为肿瘤抑制因子和癌基因的双重活性,尽管其真正的作用尚未完全了解。本综述将重点介绍与调控胃肿瘤细胞增殖、凋亡和细胞周期相关的 miRNA 研究的最新进展。我们希望深入了解 miRNA 在 GC 发生和发展中的作用机制。特别是,我们总结了与 miRNA 对 GC 细胞上皮-间充质转化、肿瘤微环境和化疗耐药性的影响相关的最新研究。我们期望阐明涉及 miRNA 的分子机制,以便更好地了解 GC 的病因,并为治疗 GC 开发新的治疗方案。